Tradjenta and Relpax drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tradjenta (linagliptin) and Relpax (eletriptan hydrobromide). Common drug interactions include tendon rupture among females.
The phase IV clinical study analyzes what interactions people have when they take Tradjenta and Relpax. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Tradjenta?
Tradjenta has active ingredients of linagliptin. It is often used in diabetes. eHealthMe is studying from 9,987 Tradjenta users. Check the latest studies of Tradjenta.
What is Relpax?
Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.
13 people who take Tradjenta and Relpax together, and have interactions are studied.
What are the common drug interactions of Tradjenta and Relpax, by gender? *:
female:
- Tendon rupture (tear of tendon)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Sinusitis (inflammation of sinus)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Arthropathy
- Intervertebral disc degeneration (spinal disc degeneration)
- Limb injury
- Road traffic accident
- Tooth disorder (tooth disease)
- House dust allergy
male:
n/a
What are the common drug interactions of Tradjenta and Relpax, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Contusion (a type of hematoma of tissue in which capillaries)
- Fall
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Joint injury
- Joint swelling
- Post procedural infection
- Tendon rupture (tear of tendon)
- Surgery
- Limb injury
- Road traffic accident
60+:
n/a
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 100.00%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 7.69%
- High Blood Pressure: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Tradjenta and Relpax?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Tradjenta and Relpax:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tradjenta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Relpax:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tradjenta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Relpax and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on linagliptin and eletriptan hydrobromide (the active ingredients of Tradjenta and Relpax, respectively), and Tradjenta and Relpax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Crixivan and Itraconazole - 5 seconds ago
- Could Prednisone cause Cytokine Storm? - 6 seconds ago
- Psoriatic Arthropathy and Idiopathic Pulmonary Fibrosis - 7 seconds ago
- Drug interactions of Gabapentin and Namenda Xr - 12 seconds ago
- Drug interactions of Biaxin and Lortab - 17 seconds ago
- Drug interactions of Irbesartan and Azathioprine Sodium - 18 seconds ago
- Drug interactions of Abilify and Novolin R - 30 seconds ago
- Seizures and Hair Loss - 36 seconds ago
- Could Fingolimod cause Diplopia? - 36 seconds ago
- Could Montelukast Sodium cause Multiple Allergies? - 37 seconds ago